These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2379746)

  • 1. A study of N-acetylneuraminic acid in relation to its potential as a marker of tumour development.
    Berns G; O'Kennedy R
    Biochem Soc Trans; 1990 Apr; 18(2):333-4. PubMed ID: 2379746
    [No Abstract]   [Full Text] [Related]  

  • 2. The determination of plasma or serum sialic acid.
    Crook M
    Clin Biochem; 1993 Feb; 26(1):31-8. PubMed ID: 8448836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of serum lipid-bound sialic acid in bladder tumours.
    Oztokatli A; Ozkardeş H; Ovül E; Erol D
    Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumours of the central nervous system and serum sialic acid concentration in men and women.
    Gatchev O; Råstam L; Lindberg G; Gullberg B; Eklund GA; Törnberg S
    Br J Cancer; 1993 Aug; 68(2):425-7. PubMed ID: 8347501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified thiobarbituric acid method for the determination of N-acetylneuraminic acid.
    Kinsella VA; Berns GJ; O'Kennedy R
    Biochem Soc Trans; 1991 Feb; 19(1):56S. PubMed ID: 2037187
    [No Abstract]   [Full Text] [Related]  

  • 8. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.
    O'Kennedy R; Berns G; Moran E; Smyth H; Carroll K; Thornes RD; O'Brien A; Fennelly J; Butler M
    Cancer Lett; 1991 Jun; 58(1-2):91-100. PubMed ID: 2049789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J; Vosmiková K; Pospísil J; Poucková P
    Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic parameters in metastatic spread of laryngeal cancer: clinico-histopathological correlations.
    Galioto GB; Mevio E; Benazzo M; Arizzi L; Scelsi M
    Clin Otolaryngol Allied Sci; 1987 Aug; 12(4):303-8. PubMed ID: 3665140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Hardy RE
    Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive history and prognosis in patients with operable breast cancer.
    Brower ST; Tartter P; Weiss S; Luderer AA; Lehrer S
    Cancer; 1995 Aug; 76(3):531-3. PubMed ID: 8625140
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid-bound sialic acid, prostaglandin E and histamine in head and neck cancer.
    Klapan I; Katić V; Culo F; Sabolović D; Cuk V; Fumić K; Simović S
    Eur J Cancer; 1993; 29A(6):839-45. PubMed ID: 8484973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total sialic acid as a tumor marker for oral cancer.
    Xing RD; Wang ZS; Li CQ; Tang QY; Jiang CB; Zhang YZ
    Int J Biol Markers; 1994; 9(4):239-42. PubMed ID: 7836802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of lipid-bound sialic acid in the plasma of mice bearing benzpyrene-induced tumors.
    Polívková J; Vosmiková K; Pospísil J
    Neoplasma; 1989; 36(6):667-71. PubMed ID: 2615870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute-phase reactants as tumor markers.
    Schwartz MK
    Cancer Invest; 1995; 13(4):444-5. PubMed ID: 7543001
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between lipid-associated sialic acid and tumor burden in melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Int J Biol Markers; 1994; 9(4):247-50. PubMed ID: 7836804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of determining the levels of lipid-bound sialic acids in the blood in cancer of the kidneys].
    Rubtsov BI; Novikov AM; Figurin KM
    Urol Nefrol (Mosk); 1988; (3):31-3. PubMed ID: 3218004
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum sialic acid and carcinoembryonic antigen for the detection of early-stage colorectal cancer.
    Tautu C; Pee D; Dunsmore M; Prorok JJ; Alhadeff JA
    J Clin Lab Anal; 1991; 5(4):247-54. PubMed ID: 1890538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.